NO20006112L - BASB027-proteiner og gener fra Moraxella Catarrhalis, antigener, antistoffer, og anvendelser - Google Patents

BASB027-proteiner og gener fra Moraxella Catarrhalis, antigener, antistoffer, og anvendelser

Info

Publication number: NO20006112L
Authority: NO; Norway
Prior art keywords: antigens; genes; antibodies; moraxella catarrhalis; basb027
Prior art date: 1998-06-03

Application number

NO20006112A

Other languages

English (en)

Other versions

NO20006112D0 (no

NO327201B1 (no

Inventor

Carlota Vinals-Bassols

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-03

Filing date

2000-12-01

Publication date

2001-02-02

1998-06-03 Priority claimed from GBGB9811945.6A external-priority patent/GB9811945D0/en

1999-03-08 Priority claimed from GBGB9905304.3A external-priority patent/GB9905304D0/en

2000-12-01 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2000-12-01 Publication of NO20006112D0 publication Critical patent/NO20006112D0/no

2001-02-02 Publication of NO20006112L publication Critical patent/NO20006112L/no

2009-05-11 Publication of NO327201B1 publication Critical patent/NO327201B1/no

Links

241000588655 Moraxella catarrhalis Species 0.000 title 1
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
238000000034 method Methods 0.000 abstract 1
102000040430 polynucleotide Human genes 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
238000010188 recombinant method Methods 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20006112A 1998-06-03 2000-12-01 BASB027-polypeptider fra Moraxella Catarrhalis, og polynukleotider som koder for disse, ekspresjonsvektorer og vertceller som inneholder disse, samt antistoffer og vaksiner, og fremgangsmate for fremstilling av polypeptidene og polynukleotidene og anvendelser av disse for fremstilling av medikamenter, samt fremgangsmate for diagnostisering av en M. Catarrhalis-infeksjon. NO327201B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9811945.6A GB9811945D0 (en)	1998-06-03	1998-06-03	Novel compounds
GBGB9905304.3A GB9905304D0 (en)	1999-03-08	1999-03-08	Novel compounds
PCT/EP1999/003822 WO1999063093A2 (en)	1998-06-03	1999-05-31	Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses

Publications (3)

Publication Number	Publication Date
NO20006112D0 NO20006112D0 (no)	2000-12-01
NO20006112L true NO20006112L (no)	2001-02-02
NO327201B1 NO327201B1 (no)	2009-05-11

Family

ID=26313784

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006112A NO327201B1 (no)	1998-06-03	2000-12-01	BASB027-polypeptider fra Moraxella Catarrhalis, og polynukleotider som koder for disse, ekspresjonsvektorer og vertceller som inneholder disse, samt antistoffer og vaksiner, og fremgangsmate for fremstilling av polypeptidene og polynukleotidene og anvendelser av disse for fremstilling av medikamenter, samt fremgangsmate for diagnostisering av en M. Catarrhalis-infeksjon.

Country Status (22)

Country	Link
US (3)	US6803043B1 (no)
EP (1)	EP1082435B1 (no)
JP (1)	JP4503177B2 (no)
KR (3)	KR20070089890A (no)
CN (1)	CN1311820B (no)
AT (1)	ATE341628T1 (no)
AU (1)	AU738896B2 (no)
BR (1)	BR9911609A (no)
CA (1)	CA2331196A1 (no)
CY (1)	CY1105820T1 (no)
CZ (1)	CZ296086B6 (no)
DE (1)	DE69933444T2 (no)
DK (1)	DK1082435T3 (no)
ES (1)	ES2274627T3 (no)
HU (1)	HUP0102235A3 (no)
IL (2)	IL139951A0 (no)
NO (1)	NO327201B1 (no)
NZ (1)	NZ508617A (no)
PL (1)	PL198031B1 (no)
PT (1)	PT1082435E (no)
TR (1)	TR200003608T2 (no)
WO (1)	WO1999063093A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0103171D0 (en)	2001-02-08	2001-03-28	Smithkline Beecham Biolog	Vaccine composition
WO2003040172A2 (en) *	2001-11-09	2003-05-15	Aegera Therapeutics, Inc.	Methods and reagents for peptide-bir interaction screens
US20060057160A1 (en)	2002-08-02	2006-03-16	Ralph Biemans	Vaccine composition
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
EP4558170A1 (en)	2022-07-19	2025-05-28	GlaxoSmithKline Biologicals S.A.	Continuous process for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9224584D0 (en) *	1992-11-23	1993-01-13	Connaught Lab	Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BE1006377A3 (fr)	1992-11-24	1994-08-09	Raffinerie Tirlemontoise Sa	Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires.
US5807978A (en) *	1995-06-07	1998-09-15	Kokolus; William J.	Immunogenic peptides of prostate specific antigen
US6090576A (en) *	1996-03-08	2000-07-18	Connaught Laboratories Limited	DNA encoding a transferrin receptor of Moraxella
US6673910B1 (en) *	1999-04-08	2004-01-06	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics

1999
- 1999-05-31 TR TR2000/03608T patent/TR200003608T2/xx unknown
- 1999-05-31 HU HU0102235A patent/HUP0102235A3/hu unknown
- 1999-05-31 EP EP99926507A patent/EP1082435B1/en not_active Expired - Lifetime
- 1999-05-31 CN CN998091995A patent/CN1311820B/zh not_active Expired - Fee Related
- 1999-05-31 IL IL13995199A patent/IL139951A0/xx active IP Right Grant
- 1999-05-31 KR KR1020077019114A patent/KR20070089890A/ko not_active Ceased
- 1999-05-31 AT AT99926507T patent/ATE341628T1/de active
- 1999-05-31 KR KR1020007013705A patent/KR100830282B1/ko not_active Expired - Fee Related
- 1999-05-31 PT PT99926507T patent/PT1082435E/pt unknown
- 1999-05-31 CA CA002331196A patent/CA2331196A1/en not_active Abandoned
- 1999-05-31 NZ NZ508617A patent/NZ508617A/en unknown
- 1999-05-31 DE DE69933444T patent/DE69933444T2/de not_active Expired - Lifetime
- 1999-05-31 BR BR9911609-0A patent/BR9911609A/pt not_active Application Discontinuation
- 1999-05-31 PL PL345193A patent/PL198031B1/pl not_active IP Right Cessation
- 1999-05-31 AU AU43732/99A patent/AU738896B2/en not_active Ceased
- 1999-05-31 CZ CZ20004510A patent/CZ296086B6/cs not_active IP Right Cessation
- 1999-05-31 DK DK99926507T patent/DK1082435T3/da active
- 1999-05-31 KR KR1020067024958A patent/KR100911277B1/ko not_active Expired - Fee Related
- 1999-05-31 US US09/701,711 patent/US6803043B1/en not_active Expired - Fee Related
- 1999-05-31 WO PCT/EP1999/003822 patent/WO1999063093A2/en not_active Ceased
- 1999-05-31 ES ES99926507T patent/ES2274627T3/es not_active Expired - Lifetime
- 1999-05-31 JP JP2000552287A patent/JP4503177B2/ja not_active Expired - Fee Related
2000
- 2000-11-28 IL IL139951A patent/IL139951A/en not_active IP Right Cessation
- 2000-12-01 NO NO20006112A patent/NO327201B1/no not_active IP Right Cessation
2004
- 2004-07-22 US US10/896,725 patent/US7641910B2/en not_active Expired - Fee Related
2006
- 2006-12-01 CY CY20061101736T patent/CY1105820T1/el unknown
2009
- 2009-11-18 US US12/621,280 patent/US20100143412A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1037209A1 (en)	2002-02-01
NO20006112D0 (no)	2000-12-01
CA2331196A1 (en)	1999-12-09
PL345193A1 (en)	2001-12-03
AU738896B2 (en)	2001-09-27
CY1105820T1 (el)	2011-02-02
KR100830282B1 (ko)	2008-05-16
KR20060129108A (ko)	2006-12-14
CZ296086B6 (cs)	2006-01-11
HUP0102235A3 (en)	2004-10-28
KR20070089890A (ko)	2007-09-03
PL198031B1 (pl)	2008-05-30
EP1082435B1 (en)	2006-10-04
KR100911277B1 (ko)	2009-08-11
ATE341628T1 (de)	2006-10-15
IL139951A (en)	2008-08-07
DK1082435T3 (da)	2007-02-05
US20100143412A1 (en)	2010-06-10
IL139951A0 (en)	2002-02-10
DE69933444T2 (de)	2007-03-29
CN1311820B (zh)	2011-11-16
WO1999063093A2 (en)	1999-12-09
US6803043B1 (en)	2004-10-12
CZ20004510A3 (cs)	2001-07-11
US7641910B2 (en)	2010-01-05
JP2002517199A (ja)	2002-06-18
EP1082435A2 (en)	2001-03-14
NO327201B1 (no)	2009-05-11
PT1082435E (pt)	2007-01-31
ES2274627T3 (es)	2007-05-16
KR20010052552A (ko)	2001-06-25
WO1999063093A3 (en)	2000-03-02
JP4503177B2 (ja)	2010-07-14
DE69933444D1 (de)	2006-11-16
AU4373299A (en)	1999-12-20
TR200003608T2 (tr)	2001-04-20
NZ508617A (en)	2003-08-29
US20040265331A1 (en)	2004-12-30
HUP0102235A1 (hu)	2001-10-28
CN1311820A (zh)	2001-09-05
BR9911609A (pt)	2001-02-06

Legal Events

Date	Code	Title	Description
2012-12-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20005952L (no)	2001-01-18	Antigene polypeptider fra Neisseria Meningitidis, tilsvarende polynukleotider og beskyttende antistoffer
NO20006112D0 (no)	2000-12-01	BASB027-proteiner og gener fra Moraxella Catarrhalis, antigener, antistoffer, og anvendelser
AU3931599A (en)	1999-11-23	Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
DK1078064T3 (da)	2006-01-02	Forbindelser fra moraxella catarrhalis
ATE281524T1 (de)	2004-11-15	Moraxella catarrhalis pilq proteine
ATE312922T1 (de)	2005-12-15	Moraxella catarrhalis polynukleotide und polypeptide
DE60019614D1 (de)	2005-05-25	Moraxella catarrhalis antigen basb117
ATE454452T1 (de)	2010-01-15	Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE399205T1 (de)	2008-07-15	Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
DE60019613D1 (de)	2005-05-25	Moraxella catarrhalis antigen basb120
ATE360073T1 (de)	2007-05-15	Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
DK1196586T3 (da)	2006-03-27	BASB111-polypeptid og -polynukleotid fra moraxella catharralis
ATE368686T1 (de)	2007-08-15	Polypeptide aus moraxella (branhamella) catarrhalis
ATE274582T1 (de)	2004-09-15	Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
WO2001009331A3 (en)	2001-07-05	Moraxella catarrhalis antigen basb125
WO2001009330A3 (en)	2001-07-05	Moraxella catarrhalis antigen basb121